Insulet
PODD
#2099
Rank
S$12.01 B
Marketcap
S$173.21
Share price
0.60%
Change (1 day)
-58.39%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): S$0.71 Billion

According to Insulet's latest financial reports the company's current earnings are S$3.05 Billion. In 2025 the company made an earning of S$0.51 Billion, an increase over its 2024 earnings that were of S$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.71 B39.56%
2025 S$0.51 B16.3%
2024 S$0.43 B36.76%
2023 S$0.32 B481.9%
2022 S$55.18 M-45.24%
2021 S$0.10 B43.35%
2020 S$70.29 M18.51%
2019 S$59.31 M41.16%
2018 S$42.02 M-711.95%
2017 -S$6.87 Million-56.85%
2016 -S$15.92 Million-79.31%
2015 -S$76.94 Million63.85%
2014 -S$46.96 Million31.04%
2013 -S$35.84 Million-21.96%
2012 -S$45.92 Million
2010 -S$43.8 Million-42.38%
2009 -S$76.01 Million-33.56%
2008 -S$0.12 Billion65.93%
2007 -S$68.95 Million209.75%
2006 -S$22.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.55 B 4,635.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.41 B 1,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$9.38 B 1,224.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$43.01 B 5,970.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-S$78.1 Million-111.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
S$0.10 B-85.03%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$1.65 B 134.01%๐Ÿ‡บ๐Ÿ‡ธ USA